Correlation between plasma levels of matrix metalloproteinase (MMP)-9/MMP-2 ratio and α-fetoproteins in chronic hepatitis carrying hepatitis B virus

被引:29
作者
Chung, TW
Kim, JR
Suh, JI
Lee, YC
Chang, YC
Chung, TH
Kim, CH [1 ]
机构
[1] Dongguk Univ, Natl Res Lab Glycobiol, Coll Oriental Med, MOST, Kyungju, Kyungbuk, South Korea
[2] Dongguk Univ, Dept Biochem & Mol Biol, Kyungju, Kyungbuk, South Korea
[3] Dongguk Univ, Dept Internal Med, Kyungju, Kyungbuk, South Korea
[4] Dong A Univ, Fac Biotechnol, Pusan, South Korea
[5] Keimyung Univ, Kidney Inst, Taegu, South Korea
[6] Kyungpook Natl Univ, WHO, Collaborating Viral Hepatitis Res Ctr, Taegu, South Korea
关键词
alpha-fetoprotein; chronic hepatitis; hepatitis B virus; hepatocellular carcinoma; matrix metalloproteinase-2; matrix metalloproteinase-9; zymography;
D O I
10.1111/j.1440-1746.2004.03344.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Matrix metalloproteases (MMP) and alpha-fetoproteins (AFP) are involved in hepatitis B virus (HBV)-induced chronic hepatitis. In the present study, we have determined the correlation between the MMP-9/MMP-9 ratio and AFP levels in the serum of patients during chronic viral B hepatitis. Methods: Twenty-eight healthy individuals (18 men and 10 women) with a mean age of 36.3 years (range 23-58 years) and 50 patients (42 men, 8 women) with a mean age of 39.7 years (range 22-61 years) participated in the study. Forty-eight participants had HBV and the remaining two were either hepatitis G virus (HGV) or hepatitis C virus (HCV) carriers. Values of patients were compared with those obtained from 12 blood donor controls (5 men, 7 women), mean age 36 years (range 21-46 years). Patient's sera were subjected to examination of hepatitis B surface (HBs) and hepatitis B early (Hbe) antigen, SGOT, SGPT, AFP, MMP-2 and MMP-9. Serum levels of MMP-2 and MMP-9 activities were measured by a zymogram protease assay and densitometric measurement. The ratios of MMP-9 to MMP-2 were calculated by dividing the densitometric results. Results: Compared with the healthy controls, the mean serum concentrations of MMP-2 were slightly increased in the chronic HBV patients. In contrast, compared with the healthy controls, the mean serum concentrations of MMP-9 were significantly increased in the chronic HBV patients. When the ratios of the MMP-9/MMP-2 and amounts of the serum AFP were compared, a specific correlation between these two parameters was observed. Higher amounts of AFP were detected in the patients with a low ratio of MMP-9/MMP-2. Patients with hepatocellular carcinoma (HCC) and cirrhosis showed relatively low MMP-9/MMP-2 ratios in chronic hepatitis B. In addition, AFP levels of HCC and cirrhosis were higher than in chronic HBV patients. Conclusions: These results indicate that the AFP level and ratio of MMP-9 and MMP-2 is highly correlated in chronic HBV induced hepatitis. Because the serum MMP activities were significantly varied between each stage of AFP production in liver disease, an individual profile of these parameters might serve as an easy accessing serum marker to monitor the progression of liver disease. (C) 2004 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 41 条
[11]   Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells [J].
Chung, TW ;
Moon, SK ;
Lee, YC ;
Kim, JG ;
Ko, JH ;
Kim, CH .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 408 (02) :147-154
[12]  
Chung TW, 2003, CANCER RES, V63, P3453
[13]   Cytokines and fibrogenesis [J].
Friedman, SL .
SEMINARS IN LIVER DISEASE, 1999, 19 (02) :129-140
[14]   Clinical implication of vascular cell adhesion molecule-1 and very late activation antigen-4 interaction, and matrix metalloproteinase-2 production in patients with liver disease [J].
Haruta, I ;
Tokushige, K ;
Komatsu, T ;
Ikeda, I ;
Yamauchi, K ;
Hayashi, N .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 13 (09) :721-727
[15]   Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling [J].
Haruyama, T ;
Ajioka, I ;
Akaike, T ;
Watanabe, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (03) :681-686
[16]  
Hayasaka A, 1996, HEPATOLOGY, V24, P1058
[17]   Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis [J].
Izzo, F ;
Cremona, F ;
Ruffolo, F ;
Palaia, R ;
Parisi, V ;
Curley, SA .
ANNALS OF SURGERY, 1998, 227 (04) :513-518
[18]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470
[19]   Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C - Relationship to interferon response [J].
Kasahara, A ;
Hayashi, N ;
Mochizuki, K ;
Oshita, M ;
Katayama, K ;
Kato, M ;
Masuzawa, M ;
Yoshihara, H ;
Naito, M ;
Miyamoto, T ;
Inoue, A ;
Asai, A ;
Hijioka, T ;
Fusamoto, H ;
Kamada, T .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :574-583
[20]   Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers [J].
Kuo, WH ;
Chou, FP ;
Lu, SC ;
Chu, SC ;
Hsieh, YS .
CLINICA CHIMICA ACTA, 2000, 294 (1-2) :157-168